GLUC - Glucose Health, Inc.

Other OTC - Other OTC Prezzo differito. Valuta in USD.
0,3895
-0,0105 (-2,63%)
Al 11:44AM EDT. Mercato aperto.
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente0,4000
Aperto0,3895
Denaro0,0000 x 0
Lettera0,0000 x 0
Min-Max giorno0,3895 - 0,3895
Intervallo di 52 settimane0,3150 - 0,9480
Volume10.705
Media Volume7.838
Capitalizzazione580.090
Beta (5 anni mensile)3,09
Rapporto PE (ttm)N/D
EPS (ttm)-0,0800
Prossima data utili06 giu 2023 - 10 giu 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    IMPORTANT CORPORATE DEVELOPMENTS - GLUCOSE HEALTH, INC. (OTC: GLUC)

    Bentonville, AR, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") confirms the following important corporate developments. Three outstanding candidates have now accepted nominations to serve as independent directors of the Company. Charters for the enactment of Audit, Compensation and Corporate Governance/Nominations committees, each comprised, or majority comprised, of the independent directors, have been established. The Company appointed a Public Company Accounti

  • GlobeNewswire

    Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022

    BENTONVILLE, AR , Oct. 24, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal 2022, for the period ended September 30, 2022, posted today at OTCMarkets.com. Q3 2022 Revenue of $340,681 vs. $234,930 for Q3 2021 = a 45% increase.Q3 2022 Gross Profit of $153,789 vs. $62,032 for Q3 2021 = a 148% increase.Q3 2022 Net Income of $8,091 vs. Q3 2021 Net Loss of $133,160. The Company additio